인플루엔자 백신 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for flu vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Flu Vaccines Market Size (2024E): USD 5.75 Billion
• Projected Market Value (2033F): USD 10.2 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Flu Vaccines Market - Report Scope:

Flu vaccines play a crucial role in preventing seasonal influenza and reducing the impact of flu outbreaks. These vaccines are essential for public health, offering protection against various strains of influenza viruses. The flu vaccines market caters to healthcare providers, hospitals, clinics, and public health organizations, offering a range of vaccine types, including trivalent and quadrivalent vaccines, as well as newer formulations targeting multiple flu strains. Market growth is driven by increasing awareness of influenza prevention, rising healthcare expenditures, and advancements in vaccine technology, enhancing vaccine efficacy and safety.

Market Growth Drivers:

The global flu vaccines market is propelled by several key factors, including growing awareness about the importance of vaccination in preventing seasonal flu and reducing healthcare burdens. The increasing incidence of influenza-related complications, particularly among vulnerable populations such as the elderly and young children, further drives market expansion. Technological advancements, such as the development of high-dose and adjuvanted vaccines, offer improved protection and stimulate market growth. Additionally, the rising adoption of vaccination programs by governments and health organizations worldwide creates a substantial demand for flu vaccines.

Market Restraints:

Despite promising growth prospects, the flu vaccines market faces challenges related to vaccine hesitancy, high production costs, and regulatory hurdles. Vaccine hesitancy, driven by concerns about vaccine safety and efficacy, can impact vaccination rates and market growth. High production costs and complex manufacturing processes pose challenges for vaccine accessibility and affordability, particularly in low- and middle-income countries. Additionally, regulatory requirements for vaccine approval and distribution create operational complexities for manufacturers, affecting market dynamics.

Market Opportunities:

The flu vaccines market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of new vaccine formulations, including those targeting multiple strains and offering longer protection, enhances market potential. Furthermore, the expanding application of flu vaccines in preventive health strategies, such as integrated vaccination programs and partnerships with public health initiatives, broadens market scope. Strategic investments in research and development, along with collaborations with healthcare providers and governmental agencies, are essential to capitalize on emerging opportunities and sustain market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the flu vaccines market globally?
• Which vaccine types and formulations are contributing to the adoption of flu vaccines across different regions?
• How are technological advancements reshaping the competitive landscape of the flu vaccines market?
• Who are the key players contributing to the flu vaccines market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global flu vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global flu vaccines market, including GlaxoSmithKline plc, Pfizer Inc., Sanofi Pasteur, and AstraZeneca, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced vaccine formulations, including high-dose and adjuvanted vaccines, catering to diverse patient needs and public health requirements. Collaborations with governmental health agencies, public health organizations, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practices, and public education enhances market growth and vaccination uptake in the dynamic flu vaccines landscape.

Key Companies Profiled:

• Sanofi Pasteur Inc.
• AstraZeneca
• Csl Ltd.
• Abbott
• GlaxoSmithKline Plc.
• Serum Institute Of India Pvt.Ltd

Key Segments Covered in Flu Vaccines Industry Research

Product:

• Trivalent Flu Vaccine
• Quadrivalent Flu Vaccine

Dosage Form:

• Intramuscular Injection
• Nasal Spray
• Intradermal Shot

Distribution Channel:

• Institutional Sales
• Retail Sales

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Value Added Insights

• 4.1. Production Strategy
• 4.2. Volume Consumption
• 4.3. Production Cost
• 4.4. Pipeline Assessment
• 4.5. Patent Analysis
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Growing government support and focus for the development of the vaccines
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Development of Vaccine Products
  • 5.2.2. Regulatory Imposition
  • 5.2.3. Increasing Expenditure on Research and Development
  • 5.2.4. Increasing Prevalence of Seasonal Flu
  • 5.2.5. Increased Vaccination Rates
  • 5.2.6. High Rate of Manufacturing
  • 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
• 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume (Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

• 8.1. Regional Pricing Analysis By Product
• 8.2. Price Break up
  • 8.2.1. Manufacturer Level
  • 8.2.2. Distributor Level
• 8.3. Global Average Pricing Analysis Benchmark
  • 8.3.1. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
  • 10.3.1. Trivalent Flu Vaccine
  • 10.3.2. Quadrivalent Flu Vaccine
• 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Dosage Form

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis, By Dosage Form, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Dosage Form, 2024-2033
  • 11.3.1. Intramuscular Injection
  • 11.3.2. Nasal Spray
  • 11.3.3. Intradermal Shot
• 11.4. Market Attractiveness Analysis By Dosage Form

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channels

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channels, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channels, 2024-2033
  • 12.3.1. Institutional Sales
    • 12.3.1.1. Hospitals
    • 12.3.1.2. Community Clinics
    • 12.3.1.3. Public Health Agencies
    • 12.3.1.4. Workplace Purchasing
  • 12.3.2. Retail Sales
    • 12.3.2.1. Retail Pharmacies
    • 12.3.2.2. Mail Order Pharmacies
• 12.4. Market Attractiveness Analysis By Distribution Channels

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (Middle East and Africa)
• 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Dosage Form
  • 14.3.4. By Distribution Channels
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Dosage Form
  • 14.4.4. By Distribution Channels
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. U.S. Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Dosage Form
      • 14.8.1.2.3. By Distribution Channels
  • 14.8.2. Canada Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Dosage Form
      • 14.8.2.2.3. By Distribution Channels

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By Dosage Form
  • 15.3.4. By Distribution Channels
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Dosage Form
  • 15.4.4. By Distribution Channels
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Mexico Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Dosage Form
      • 15.8.1.2.3. By Distribution Channels
  • 15.8.2. Brazil Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Dosage Form
      • 15.8.2.2.3. By Distribution Channels
  • 15.8.3. Argentina Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Dosage Form
      • 15.8.3.2.3. By Distribution Channels

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Russia
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Dosage Form
  • 16.3.4. By Distribution Channels
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Dosage Form
  • 16.4.4. By Distribution Channels
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Dosage Form
      • 16.8.1.2.3. By Distribution Channels
  • 16.8.2. Italy Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Dosage Form
      • 16.8.2.2.3. By Distribution Channels
  • 16.8.3. France Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Dosage Form
      • 16.8.3.2.3. By Distribution Channels
  • 16.8.4. U.K. Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Dosage Form
      • 16.8.4.2.3. By Distribution Channels
  • 16.8.5. Spain Market Analysis
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Dosage Form
      • 16.8.5.2.3. By Distribution Channels
  • 16.8.6. BENELUX Market Analysis
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Dosage Form
      • 16.8.6.2.3. By Distribution Channels
  • 16.8.7. Russia Market Analysis
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Dosage Form
      • 16.8.7.2.3. By Distribution Channels

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Dosage Form
  • 17.3.4. By Distribution Channels
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Dosage Form
  • 17.4.4. By Distribution Channels
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. China Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Dosage Form
      • 17.8.1.2.3. By Distribution Channels
  • 17.8.2. Japan Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Dosage Form
      • 17.8.2.2.3. By Distribution Channels
  • 17.8.3. South Korea Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Dosage Form
      • 17.8.3.2.3. By Distribution Channels

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. India
    • 18.3.1.2. Indonesia
    • 18.3.1.3. Malaysia
    • 18.3.1.4. Thailand
    • 18.3.1.5. Rest of South Asia
  • 18.3.2. By Product
  • 18.3.3. By Dosage Form
  • 18.3.4. By Distribution Channels
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Dosage Form
  • 18.4.4. By Distribution Channels
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. India Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Dosage Form
      • 18.8.1.2.3. By Distribution Channels
  • 18.8.2. Indonesia Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Dosage Form
      • 18.8.2.2.3. By Distribution Channels
  • 18.8.3. Malaysia Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Dosage Form
      • 18.8.3.2.3. By Distribution Channels
  • 18.8.4. Thailand Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Dosage Form
      • 18.8.4.2.3. By Distribution Channels

19. Oceania Market 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Dosage Form
  • 19.3.4. By Distribution Channels
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Dosage Form
  • 19.4.4. By Distribution Channels
• 19.5. Market Trends
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Players - Intensity Mapping
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Dosage Form
      • 19.8.1.2.3. By Distribution Channels
  • 19.8.2. New Zealand Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Dosage Form
      • 19.8.2.2.3. By Distribution Channels

20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkiye
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Dosage Form
  • 20.3.4. By Distribution Channels
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Dosage Form
  • 20.4.4. By Distribution Channels
• 20.5. Market Trends
• 20.6. Drivers and Restraints - Impact Analysis
• 20.7. Key Players - Intensity Mapping
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Market Analysis
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Dosage Form
      • 20.8.1.2.3. By Distribution Channels
  • 20.8.2. Turkiye Market Analysis
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Dosage Form
      • 20.8.2.2.3. By Distribution Channels
  • 20.8.3. South Africa Market Analysis
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Dosage Form
      • 20.8.3.2.3. By Distribution Channels
  • 20.8.4. North Africa Market Analysis
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By Dosage Form
      • 20.8.4.2.3. By Distribution Channels

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Sanofi Pasteur Inc.
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Key Financials
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Strategy Overview
  • 22.3.2. Astrazeneca
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Key Financials
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Strategy Overview
  • 22.3.3. Csl Ltd.
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Key Financials
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Strategy Overview
  • 22.3.4. Abbbott
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Key Financials
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Strategy Overview
  • 22.3.5. Glaxosmithkline Plc.
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Key Financials
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Strategy Overview
  • 22.3.6. Serum Institute of India Pvt.Ltd
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Key Financials
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology